Marta Wosinska

Chief Healthcare Economist
Department of Health and Human Services, Office of Inspector General

Papers:

Coverage and Out-of-Pocket Spending on Brand versus Generic/Biosimilar Specialty Drugs in Medicare Part D

American Society of Health Economists (ASHEcon)

1100 Vermont Avenue NW Suite 650

Washington, DC 20005

P: (202) 737 6608

F: (202) 496 0134

Copyright © 2017 ASHEcon - All rights reserved.